Live feed08:00:00·838dPRReleasevia QuantisnowXOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value RightByQuantisnow·Wall Street's wire, on your screen.KNTE· Kinnate Biopharma Inc.XOMA· XOMA Royalty CorporationHealth Care
